NCT06640413
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06640413
Title A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination with L19-IL2 As a Treatment of Metastatic FAP-positive Solid Tumors (Theratri)
Acronym Theratri
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Philogen S.p.A.
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
ASST Papa Giovanni XXIII Piazza OMS RECRUITING Bergamo Bergamo 24127 Italy Details
Fondazione IRCCS Istituto Nazionale dei Tumori RECRUITING Milan Milano 20133 Italy Details
Istituto Europeo di Oncologia NOT_YET_RECRUITING Milan Milano 20141 Italy Details
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" Via Mariano Semmola NOT_YET_RECRUITING Napoli Napoli 80131 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field